Sodium thiosulphate attenuates brain inflammation induced by systemic lipopolysaccharide administration in C57BL/6J mice
- 19 May 2017
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 25 (5) , 585-593
Abstract
It has been demonstrated that peripheral infections accompanied by neuroinflammation may modify brain development or affect normal brain aging and represent major risk factors for the development of neurological disorders. A wide range of synthetic and natural compounds with anti-inflammatory properties have been evaluated in animal models of neuroinflammation and neurodegeneration as an adjuvant therapeutic strategy. In the present study we have demonstrated for the first time that sodium thiosulphate (STS), a known antidote approved for treatment of certain medical conditions, is capable of reducing brain inflammation caused by systemic LPS administration. STS reduced brain levels of pro-inflammatory cytokine interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2), ionized calcium binding adaptor molecule 1 (Iba-1) and 18 kDa translocator protein (TSPO) in an animal model of systemic LPS-induced neuroinflammation. In addition, we demonstrated for the first time elevated TSPO expression in retinal ganglion cells layer after peripheral LPS challenge and inhibition of ocular TSPO expression after treatment with STS. We think that STS may be used as an adjuvant anti-inflammatory therapy for many pathological conditions associated with inflammation in the brain.Keywords
Funding Information
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México (201116)
- Consejo Nacional de Ciencia y Tecnología, Mexico (177269)
This publication has 65 references indexed in Scilit:
- Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosisJournal of Neuroinflammation, 2014
- Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in MiceMediators of Inflammation, 2013
- Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 miceBMC Neuroscience, 2013
- Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1PLOS ONE, 2012
- Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6Journal of Neuroinflammation, 2011
- Caffeine attenuates lipopolysaccharide-induced neuroinflammationNeuroscience Letters, 2010
- Role of Infection in the Pathogenesis of Alzheimerʼs DiseaseCNS Drugs, 2009
- Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2Journal of Neuroinflammation, 2008
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008
- Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brainBrain, Behavior, and Immunity, 2007